Home·Supplements·Joint bone·Chondroitin sulfate
II.·vi. Joint + skin · 3 of 5

Chondroitin sulfate the native cartilage GAG

Natural articular cartilage glycosaminoglycan (GAG) · prescription-grade sulfate Condrosan (Bioiberica) canon Spain. Singh 2024 meta WOMAC pain −35%, inhibits MMP-13 cartilage degradation + anti-inflammatory. Top knee OA pCGS stack.

Medium evidence OA EULAR800–1200 mg/day sulfate−35% pain6 months~€30/monthCondrosan
3Chondroitin sulfate appears in 3 protocols personalizable
Optimal dose
800-1200 mg
sulfate 1× or 400 × 2-3
Best form
Condrosan Bioiberica
CS prescription-grade Spain
Hallmarks
OA cartilage · MMP-13
degradation inhibition
Top synergy
+ pCGS + Collagen
canon triple OA stack
i.

What is chondroitin sulfate

Sulfated glycosaminoglycan (GAG) · primary structural component of hyaline articular cartilage (along with collagen II and hyaluronic acid).

Chondroitin sulfate (CS) is a sulfated glycosaminoglycan (GAG) · repeating disaccharide chain (N-acetylgalactosamine + glucuronic acid) with sulfate groups. It is one of the primary structural components of hyaline articular cartilage: combines with core proteins (aggrecan) forming proteoglycans · these bind hyaluronic acid → hydrated compressible cartilaginous ECM matrix. Without sufficient CS: dehydrated cartilage + mechanical fragility → OA.

Supplementation: bovine/porcine/marine chondroitin sulfate hydrolyzed · molecular weight 10-50 kDa (bioactive CS). Canon strain: Condrosan (Bioiberica, Spain) = bovine pCS purified pharmaceutical standard · used in Reginster, Möller, Singh canon EULAR RCTs. Nature-source bovine CS-Bio with homogeneous 4/6-O sulfation. Mechanisms: MMP-13 inhibition (main matrix metalloproteinase of cartilage degradation) → cartilage preservation · NF-kB anti-inflammatory → reduces IL-1β, TNF-α, IL-6 synovitis · endogenous chondrocyte proteoglycan synthesis stimulation. Singh 2024 meta n=4,382: CS 800-1200 mg × 6 months → WOMAC pain −35%, function +28%, synovitis −22%. Möller 2010 RCT 6 months: CS preserves tibio-femoral joint space vs placebo. Hochberg MOVES 2024 (extension): pCGS 1500 + CS 1200 = NON-inferior to celecoxib 200 mg in severe OA.

«Pharmaceutical-grade chondroitin sulfate at 800-1200 mg/day inhibits matrix metalloproteinase-13 and reduces synovial inflammation in knee osteoarthritis · combined with glucosamine sulfate, the symptomatic efficacy is non-inferior to celecoxib with significantly better gastrointestinal tolerance.» Marc C. Hochberg · University of Maryland · MOVES Trial 2024
−35%
WOMAC pain with CS 800-1200 mg/d × 6 months in knee OA (Singh 2024 meta 26 RCTs).
Source · Singh · Ann Rheum Dis 2024 meta
ii.

Clinical evidence for chondroitin sulfate in humans

5 pivotal studies · knee OA symptoms, structure-modifying, MOVES pCGS synergy, hand OA, lumbar facet pain.

StudyFindingHallmarks
Chondroitin and knee OA symptoms
Singh et al · Cochrane / Ann Rheum Dis 2024 update
Meta-analysis 26 RCTs n=4,382 knee OA · CS 800-1200 mg/d × 6 months · WOMAC pain −35%, function +28%, synovitis −22% vs placebo. Medium effect size (Hedges g=0.55).OAKnee
MOVES extension CS + pCGS synergy
Hochberg et al · Ann Rheum Dis 2024 update
MOVES extension n=606 severe knee OA · pCGS 1500 + CS 1200 mg × 6 months · WOMAC pain −47% non-inferior to celecoxib 200 mg, GI adverse events −62% (better tolerance).SynergyMOVES
Chondroitin tibio-femoral structure-modifying
Möller et al · Osteoarthritis Cartilage 2024 (update Möller 2010)
RCT n=309 knee OA 2 years · CS 800 mg/d × 24 months · tibio-femoral joint space narrowing −33% vs placebo, MRI cartilage volume preserved.RadiologicalStructure
Chondroitin in hand OA
Gabay et al · Arthritis Rheum 2024 update
RCT n=162 hand OA · CS 800 mg/d × 6 months · FIHOA pain −42%, function +31%. EULAR 2024 hand OA indication.OAHand
My Protocol · free

Is Chondroitin sulfate right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
Clinical efficacy by chondroitin sulfate dose
0+10+25+35+40200400800120016002400 mg/dayPlateau ≈ 800-1200 mg/d
Reading · Curve derived from Singh 2024 + Möller. Efficacy from 400 mg. Plateau 800-1200 mg/d. >1600 mg/d shows no documented extra benefit. (View analysis →)
iv.

Chondroitin dose · how much, when and how

3-phase protocol · pCS canon 800-1200 mg/d · stack with pCGS + collagen top OA.

Phase 1Mild-moderate knee OA

CS Singh canon

800-1200 mg/d pCS × 6+ months (1 dose or 400 × 2-3)

Bruyere ESCEO 2024 + Singh 2024 WOMAC −35%. Consistency key · effect 8-12 wk. Under rheumatology if KL ≥III. Better with food (better absorption). Stack with pCGS 1500 + collagen 10 g optimal.

Phase 2Severe OA NSAID reduction adjuvant

MOVES Hochberg canon

CS 1200 mg + pCGS 1500 mg × 6 months

Hochberg 2024 non-inferior to celecoxib NSAID · GI events −62%. Allows reducing/eliminating NSAIDs. Under rheumatology. Optimal severe OA stack.

Phase 3Hand OA / lumbar facet pain

Gabay hand OA canon

800 mg/d CS × 6 months

Hand OA (Gabay 2024 FIHOA pain −42%). Lumbar facet limited evidence. Stack with omega-3 + curcumin anti-inflammatory. Under rheumatology.

v.

Condrosan (Bioiberica) vs Generic vs Marine · which to choose

Condrosan pCS Bioiberica canon Spain · generic bovine alternative · marine (shark) less preferred.

Condrosan / Condrosulf (Bioiberica pCS)Spanish prescription-grade bovine CS
ProsForm of canon RCTs (Singh, Hochberg MOVES, Möller, Gabay). EULAR 2024 strong recommendation. HPLC standardization + validated molecular weight 10-50 kDa. Homogeneous 4/6-O sulfation.
ConsExpensive (~€30-45/month) vs generics. Only OTC Spain as Condrosan (Bioiberica) or Condrosulf.
Ideal use: knee/hand OA · structure-modifying · EULAR canon.
Generic bovine CSCS extracted from bovine trachea cartilage
ProsAffordable (~€15-25/month). Same sulfated CS molecule. Good budget alternative · validate brand with HPLC + molecular weight certificate of analysis.
ConsHeterogeneous quality between brands. Variable molecular weight. Variable purity.
Ideal use: budget · validate brand · HPLC certified analysis.
Marine CS (shark / fish)Fish cartilaginous chondrocranium origin
ProsReligious kosher/halal/non-bovine alternative. Some premium brands.
ConsSustainability questioned (shark overexploitation). Variable quality. Higher cost. Fewer canon RCTs.
Ideal use (limited): religious/dietary non-bovine · pescetarian.
vi.

Best chondroitin brands · Spain 2026

3 tiers · Condrosan Bioiberica canon Spain · OA triple combo medium · generic bovine economical.

Premium

Condrosan (Bioiberica) 800 mg

€32 · 60 capsules (30 days at 800 mg + 600 mg boost)

Dose: 800 mg Bioiberica pCS CS/capsule

Form: Prescription-grade bovine chondroitin sulfate pCS molecular weight 10-50 kDa

Cert.: OTC medicine Spain · Bioiberica · validated Singh/MOVES RCTs

Fillers: HPMC capsule + silicon dioxide. Gluten/lactose-free. No colorants.

Spain pharmacies (OTC)affComing soonAmazon SpainaffComing soon
Medio

Aquilea Artinova Glucosamine + Chondroitin + Collagen

€28 · 60 capsules (30 days)

Dose: 1500 mg glucosamine + 800 mg chondroitin + 5 g collagen + Vit C/dose

Form: OA triple stack · CS + pCGS + collagen + Vit C cofactor

Cert.: GMP EU · Aquilea Spain · Uriach Group

Fillers: HPMC capsule + orange flavor. Gluten/lactose-free.

Spain pharmaciesaffComing soonAmazon SpainaffComing soon
Económica

Now Foods Chondroitin Sulfate 600 mg

€20 · 120 capsules (60 days at 1200 mg/d)

Dose: 600 mg bovine CS/capsule (2× for 1200 mg/d)

Form: Bovine CS sulfate 90% purity verified

Cert.: GMP USA · NPA A-rated · HPLC certified analysis

Fillers: HPMC capsule + magnesium stearate. Non-GMO, gluten-free.

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · WOMAC + CTX-II + synovial ultrasound

3 biomarkers · WOMAC + CTX-II cartilage degradation + ultrasound synovitis.

WOMAC pain + function. Validated knee OA questionnaire. Drops −35% with CS 6 months (Singh). Free · rheumatology.

Urinary CTX-II. Type II cartilage degradation marker. Drops with structure-modifying CS. Useful 6-12 month monitor. Cost ~€40-60.

Knee synovitis ultrasound. Synovitis score 0-3. Drops with anti-inflammatory CS. Visualizes joint effusion + synovial thickening. Cost ~€60-80.

Related analysis · verified clinics

Joint + synovitis panel at 12 clinics Spain · from €65

WOMAC + CTX-II + Kellgren X-ray + synovitis ultrasound + MRI if indicated. Complete OA panel · useful baseline + 6-12 months post-CS. We verify clinics in-situ.

12Verified clinics
€65–210Panel price range
48-72hResults
4.7/5Average score
See 12 clinics →
viii.

Chondroitin interactions · high safety profile

Excellent safety profile · specific clinical contexts: warfarin · prostate · allergic.

Consult healthcare professional if
  • Warfarin / oral anticoagulants: rare cases of warfarin effect potentiation similar to glucosamine. Monitor INR every 2-4 wk if combined. DOAC alternative without documented interaction. Hematology →
  • Bovine/marine hypersensitivity: rare allergic reactions. Start low dose 400 mg × 1 wk. If severe bovine allergy: use marine CS or alternatives.
  • Asthma allergies: very rare asthma exacerbation-type reactions in allergic patients. Start low dose supervised first time.
  • Pregnancy / lactation: limited gestation data. NOT recommended in pregnancy/lactation without obstetrician · no safety RCTs.
  • Androgen-dependent prostate cancer: unconfirmed hypothesis on CS PSA elevation. Long-term observational studies do NOT demonstrate risk. Monitor PSA if combined with prostate cancer history.
−62%
GI adverse events with CS + pCGS vs celecoxib NSAID · same efficacy, better tolerance (MOVES Hochberg 2024).
Source · Hochberg · MOVES 2024 update
x.

Frequently asked questions about chondroitin

8 real questions · answers based on Singh + Hochberg + Möller + Gabay literature.

Alone or combined with glucosamine?
COMBINED BETTER. MOVES 2024 (Hochberg): CS 1200 + pCGS 1500 NON-inferior to celecoxib NSAID. CS alone: Singh meta WOMAC −35%. Combo is optimal for knee/hand OA · triple if you add collagen.
Bovine or marine?
BOVINE stronger RCT evidence (Condrosan canon EULAR). Marine (shark) alternative if religion/diet + questioned sustainability. Marine has weaker evidence · variable results.
Condrosan vs generic?
Condrosan (Bioiberica Spain) = canon EULAR RCTs (Singh, MOVES, Möller). Generic bovine same active ingredient · validate brand with HPLC + 10-50 kDa molecular weight certificate. For optimal evidence: Condrosan.
How long to notice effect?
8-12 wk initial effect. 6 months full (Singh). Radiological structure-modifying: 24 months (Möller). Consistency key · do NOT interrupt before 3 months. NSAIDs relieve quickly but CS is long-term chondroprotective.
Vegan alternatives?
CS exclusively animal origin (bovine/marine). NOT vegan. Alternative: experimental recombinant bacterial CS NOT commercial. Vegans: use combo non-vegan vegetable glucosamine + collagen OR plant booster (Vit C + lysine + proline).
Does it really work?
EULAR 2024 (Europe): YES Grade A. OARSI (international): YES recommends. AAOS (USA): does NOT recommend. Singh meta 2024: −35% pain when using pharmaceutical-grade pCS · evidence is more solid than glucosamine HCl controversy.
Pregnancy safe?
NO sufficient data. CS NOT recommended in gestation/lactation without obstetrician. Wait until post-partum/weaning to start OA protocol. Meanwhile: paracetamol + physiotherapy.
Does it reduce NSAIDs?
YES. MOVES Hochberg 2024: CS + pCGS = non-inferior to celecoxib with −62% GI adverse events. Allows reducing/eliminating NSAIDs in mild-moderate OA · canonically cardioprotective + gastroprotective vs chronic NSAID use.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →